Search by Drug Name or NDC
NDC 00078-0827-99 BEOVU 6 mg/.05mL Details
BEOVU 6 mg/.05mL
BEOVU is a INTRAVITREAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is BROLUCIZUMAB.
MedlinePlus Drug Summary
Brolucizumab-dbll injection is used to treat wet age-related macular degeneration (AMD; an ongoing disease of the eye that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities). Brolucizumab-dbll injection is also used to treat diabetic macular edema (DME; an eye disease caused by diabetes that can lead to vision loss). Brolucizumab-dbll is in a class of medications called vascular endothelial growth factor A (VEGF-A) antagonists. It works by stopping abnormal blood vessel growth and leakage in the eye(s) that may cause vision loss.
Related Packages: 00078-0827-99Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Brolucizumab-dbll Injection
Product Information
| NDC | 00078-0827 |
|---|---|
| Product ID | 0078-0827_ae4eb3f7-4799-4d79-ac61-6bc5787f0b5e |
| Associated GPIs | 8665502520E525 86655025202020 |
| GCN Sequence Number | 081193 |
| GCN Sequence Number Description | brolucizumab-dbll SYRINGE 6MG/0.05ML INTRAOCULR |
| HIC3 | Q2F |
| HIC3 Description | OPHTH. VEGF-A RECEPTOR ANTAG. RCMB MC ANTIBODY |
| GCN | 48235 |
| HICL Sequence Number | 046051 |
| HICL Sequence Number Description | BROLUCIZUMAB-DBLL |
| Brand/Generic | Brand |
| Proprietary Name | BEOVU |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | brolucizumab |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVITREAL |
| Active Ingredient Strength | 6 |
| Active Ingredient Units | mg/.05mL |
| Substance Name | BROLUCIZUMAB |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA761125 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00078-0827-99 (00078082799)
| NDC Package Code | 0078-0827-99 |
|---|---|
| Billing NDC | 00078082799 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (0078-0827-99) / .05 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2019-10-07 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |